VIOLIN: Vaccine Investigation and Online Information Network

Vaccine Detail

MAGE-A3/HPV 16 Peptide Vaccine

Vaccine Information

Vaccine Name: MAGE-A3/HPV 16 Peptide Vaccine
Target Pathogen: Cancer
Target Disease: Cancer
Vaccine Ontology ID: VO_0007569
Type: Other
Status: Clinical trial
Host Species for Licensed Use: Human
Host Species as Laboratory Animal Model: Human
MAGEA3 gene engineering:
- Type: Recombinant protein preparation
- Description: (Zandberg et al., 2015)
- Detailed Gene Information: Click Here.
Description: NULL

Host Response

References

Zandberg et al., 2015: Zandberg DP, Rollins S, Goloubeva O, Morales RE, Tan M, Taylor R, Wolf JS, Schumaker LM, Cullen KJ, Zimrin A, Ord R, Lubek JE, Suntharalingam M, Papadimitriou JC, Mann D, Strome SE, Edelman MJ. A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN). Cancer immunology, immunotherapy : CII. 2015; 64(3); 367-379. [PubMed: 25537079].